Cameco’s May Milestones: Earnings and Strategy in Focus

Cameco Corporation’s shareholders are set for a busy start to May, with two significant corporate events scheduled just days apart. The uranium producer will release its first-quarter 2026 financial results on May 5, followed by its virtual Annual Meeting of Shareholders on May 7. This condensed calendar brings strategic questions surrounding the company’s future into sharp relief.

Valuation Premium and Growth Projections

The market currently prices Cameco’s shares at a significant premium. Its forward price-to-earnings ratio stands at 97.2, which is substantially higher than the sector average of 14.6, though closer to its own five-year average of 82.6. This valuation is largely supported by consensus growth estimates. Analysts project earnings per share (EPS) growth of 63.6% for 2027, followed by a further 25.7% increase in 2028. The key question for investors is whether the company’s strategic assets can deliver on these high expectations.

A Strong Foundation from Fiscal 2025

The company enters this period from a position of strength, coming off a robust fiscal 2025. Cameco’s adjusted EBITDA increased by approximately $398 million to reach $1.9 billion. Its net margin expanded significantly to 16.93%, a notable jump from its five-year average of 5.76%. This performance was driven by higher realized uranium prices and revenue contributions from the Westinghouse segment, specifically from the Dukovany nuclear power plant project.

Strategic Assets: GLE and Westinghouse

Two strategic holdings are central to Cameco’s future valuation: its stake in Global Laser Enrichment (GLE) and its ownership of Westinghouse.

Should investors sell immediately? Or is it worth buying Cameco?

Cameco holds a 49% interest in GLE, a joint venture with Australia’s Silex Systems. The venture received a U.S. federal funding award for laser enrichment technology in January 2026. A key de-risking milestone was achieved in October 2025 when the SILEX technology reached Technology Readiness Level (TRL) 6. Plans are underway to develop a commercial facility in Western Kentucky by 2030. The market has so far assigned little optionality value to this asset.

Similarly, the potential of Westinghouse remains a focal point. An agreement from October 2025 between the U.S. government, Brookfield Asset Management, and Cameco hinted at a potential future separate public listing for the nuclear services business. Analyst estimates suggest the unit could be worth over $30 billion by 2030, representing a substantial premium to the original acquisition price of approximately $4.5 billion.

Analyst Sentiment and Price Targets

Wall Street’s view on Cameco is predominantly positive. Out of 17 analysts covering the stock, eleven rate it a “Strong Buy.” UBS analyst George Eadie recently maintained a “Hold” rating but raised his price target from $100.66 to $111.44 per share. The most bullish outlook comes from Canaccord Genuity, with a price target of $133.

The coming days will provide shareholders with crucial updates on whether the company’s operational performance and strategic direction can justify its current market valuation.